- Home
- IZM vs DYAI Comparison
IZM vs DYAI Comparison
Compare IZM & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- DYAI
- Stock Information
- Founded
- IZM 2011
- DYAI 1979
- Country
- IZM China
- DYAI United States
- Employees
- IZM N/A
- DYAI N/A
- Industry
- IZM Consumer Electronics/Video Chains
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IZM Consumer Discretionary
- DYAI Health Care
- Exchange
- IZM Nasdaq
- DYAI Nasdaq
- Market Cap
- IZM 28.7M
- DYAI 29.6M
- IPO Year
- IZM 2023
- DYAI 2004
- Fundamental
- Price
- IZM $2.59
- DYAI $0.94
- Analyst Decision
- IZM
- DYAI Strong Buy
- Analyst Count
- IZM 0
- DYAI 1
- Target Price
- IZM N/A
- DYAI $6.00
- AVG Volume (30 Days)
- IZM 29.5K
- DYAI 61.6K
- Earning Date
- IZM 07-25-2025
- DYAI 08-12-2025
- Dividend Yield
- IZM N/A
- DYAI N/A
- EPS Growth
- IZM N/A
- DYAI N/A
- EPS
- IZM N/A
- DYAI N/A
- Revenue
- IZM $180,553,977.00
- DYAI $3,554,344.00
- Revenue This Year
- IZM N/A
- DYAI $22.56
- Revenue Next Year
- IZM N/A
- DYAI $30.95
- P/E Ratio
- IZM N/A
- DYAI N/A
- Revenue Growth
- IZM N/A
- DYAI 57.59
- 52 Week Low
- IZM $1.18
- DYAI $0.91
- 52 Week High
- IZM $3.19
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- IZM 56.02
- DYAI 46.80
- Support Level
- IZM $2.50
- DYAI $0.91
- Resistance Level
- IZM $2.74
- DYAI $0.99
- Average True Range (ATR)
- IZM 0.10
- DYAI 0.06
- MACD
- IZM -0.00
- DYAI 0.00
- Stochastic Oscillator
- IZM 57.89
- DYAI 33.40
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.